Small cell lung cancer (SCLC) accounts for approximately 13% of all lung cancers, and it is a highly aggressive, poorly differentiated, high-grade neuroendocrine carcinoma2. Compared with non-small cell lung cancer (NSCLC), SCLC is characterized by a rapid multiplication time, early and ...
Stage and grade alone only have limited predictive values in stratifying survival outcomes in patients with squamous cell carcinoma (log-rank testPvalue>0.2;Fig. 4a,b)19. To validate the generalizability of our survival prediction method to other lung cancers, we utilized similar informatics workflow...